Unmodified official OCDS data retained by Tenderline for this procurement process.
Complete current OCDS release JSON
{
"id": "020567-2023",
"tag": [
"awardUpdate",
"contractUpdate"
],
"date": "2023-07-18T08:40:49+01:00",
"ocid": "ocds-h6vhtk-03e2c5",
"buyer": {
"id": "GB-FTS-322",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")"
},
"links": [
{
"rel": "prev",
"href": "https://ted.europa.eu/udl?uri=TED:NOTICE:339939-2019:TEXT:EN:HTML"
},
{
"rel": "canonical",
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000730349"
}
],
"awards": [
{
"id": "020567-2023-NP92619(a-d)-1",
"title": "NP92619 ERT Medicines",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-11331",
"name": "Aventis Pharma Ltd Trading As Sanofi"
}
],
"relatedLots": [
"1"
]
}
],
"tender": {
"id": "NP92619 (a-d)",
"lots": [
{
"id": "1",
"description": "The following Framework Agreements have been extended and are for the supply of the following ERT Medicines to NHS Scotland: NP92619 (a) Laronidase - Aldurazyme® NP92619 (b) Imiglucerase - Cerezyme® NP92619 (c) Agalsidase Beta - Fabrazyme® NP92619 (d) Alglucosidase Alfa - Myozyme®.",
"contractPeriod": {
"endDate": "2023-09-30T23:59:59+01:00",
"startDate": "2019-10-01T00:00:00+01:00"
}
}
],
"items": [
{
"id": "1",
"relatedLot": "1",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
}
],
"title": "NP92619 ERT Medicines",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"reviewDetails": "Economic operators should approach the contracting authority in the first instance. However, the only formal remedy is to apply to the courts:\nAn economic operator that suffers, or is at risk of suffering, loss, or damage attributable to a breach of duty under the Public Contracts (Scotland) Regulations 2015 or the Procurement Reform (Scotland) Act 2014, may bring proceedings in the Sheriff Court or the Court of Session.\nThe bringing of court proceedings against the Authority after the Framework Agreement has been entered into will not affect the Framework Agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the Framework Agreement has been entered into are limited to the award of damages.",
"classification": {
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
},
"mainProcurementCategory": "goods"
},
"parties": [
{
"id": "GB-FTS-322",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")",
"roles": [
"buyer"
],
"address": {
"region": "UKM",
"locality": "Edinburgh",
"postalCode": "EH12 9EB",
"countryName": "United Kingdom",
"streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent"
},
"details": {
"url": "http://www.nss.nhs.scot/browse/procurement-and-logistics",
"buyerProfile": "https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883"
},
"identifier": {
"legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")"
},
"contactPoint": {
"name": "Michelle Semple",
"email": "michelle.semple3@nhs.scot"
}
},
{
"id": "GB-FTS-11331",
"name": "Aventis Pharma Ltd Trading As Sanofi",
"roles": [
"supplier"
],
"address": {
"region": "UK",
"locality": "Reading",
"postalCode": "RG6 1PT",
"countryName": "United Kingdom",
"streetAddress": "410 Thames Valley Park Drive"
},
"details": {
"scale": "large"
},
"identifier": {
"legalName": "Aventis Pharma Ltd Trading As Sanofi"
},
"contactPoint": {
"telephone": "+44 1183543118"
}
},
{
"id": "GB-FTS-324",
"name": "Sheriff Court House",
"roles": [
"reviewBody"
],
"address": {
"locality": "Edinburgh",
"postalCode": "EH1 1LB",
"countryName": "United Kingdom",
"streetAddress": "27 Chambers Street"
},
"details": {
"url": "https://www.scotcourts.gov.uk/the-courts/court-locations/edinburgh-sheriff-court-and-justice-of-the-peace-court"
},
"identifier": {
"legalName": "Sheriff Court House"
},
"contactPoint": {
"email": "edinburgh@scotcourts.gov.uk"
}
}
],
"language": "en",
"contracts": [
{
"id": "020567-2023-NP92619(a-d)-1",
"items": [
{
"id": "1",
"relatedLot": "1",
"classification": {
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
},
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
]
}
],
"title": "NP92619 ERT Medicines",
"value": {
"amount": 20056400,
"currency": "GBP"
},
"period": {
"durationInDays": 360
},
"status": "active",
"awardID": "020567-2023-NP92619(a-d)-1",
"amendments": [
{
"id": "1",
"rationale": "Need for modification brought about by circumstances which a diligent contracting authority/entity could not foresee: This modification is necessary to meet the additional demands of the Scottish Health and Social Care sector during the Covid-19 pandemic and associated recovery, to maintain supply and remove unnecessary disruption from the Authority due to circumstances unforeseen by the Authority in line with Regulation 72(1)(c) of the Public Contracts (Scotland) Regulations 2015.",
"description": "This modification effects an extension of the Framework Agreement duration from 01 October 2023 until 30 September 2024. The modification notice covers the individual Framework Agreements. All Terms and Conditions of Contract remain in place."
}
],
"dateSigned": "2019-08-07T00:00:00+01:00"
}
],
"description": "The estimated values of the Framework Agreements referred to in Section V.2.4 covers the twenty one (21) month contract duration and the twenty seven (27) month extension period of the Framework Agreement.\nOJEU notice numbers for each of the individual Awards:\nNP92619(a)Aldurazyme®- 2019/S 170-415123\nNP92619(b)Cerezyme®- 2019/S 170-415129\nNP92619(c)Fabrazyme®- 2019/S 170-415117\nNP92619(d)Myozyme®- 2019/S 170-415133\n(SC Ref:730349)",
"initiationType": "tender"
}Complete JSON history (1 releases)
18 Jul 2023 · 020567-2023 · awardUpdate, contractUpdate
{
"id": "020567-2023",
"tag": [
"awardUpdate",
"contractUpdate"
],
"date": "2023-07-18T08:40:49+01:00",
"ocid": "ocds-h6vhtk-03e2c5",
"buyer": {
"id": "GB-FTS-322",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")"
},
"links": [
{
"rel": "prev",
"href": "https://ted.europa.eu/udl?uri=TED:NOTICE:339939-2019:TEXT:EN:HTML"
},
{
"rel": "canonical",
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000730349"
}
],
"awards": [
{
"id": "020567-2023-NP92619(a-d)-1",
"title": "NP92619 ERT Medicines",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-11331",
"name": "Aventis Pharma Ltd Trading As Sanofi"
}
],
"relatedLots": [
"1"
]
}
],
"tender": {
"id": "NP92619 (a-d)",
"lots": [
{
"id": "1",
"description": "The following Framework Agreements have been extended and are for the supply of the following ERT Medicines to NHS Scotland: NP92619 (a) Laronidase - Aldurazyme® NP92619 (b) Imiglucerase - Cerezyme® NP92619 (c) Agalsidase Beta - Fabrazyme® NP92619 (d) Alglucosidase Alfa - Myozyme®.",
"contractPeriod": {
"endDate": "2023-09-30T23:59:59+01:00",
"startDate": "2019-10-01T00:00:00+01:00"
}
}
],
"items": [
{
"id": "1",
"relatedLot": "1",
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
],
"additionalClassifications": [
{
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
}
]
}
],
"title": "NP92619 ERT Medicines",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"reviewDetails": "Economic operators should approach the contracting authority in the first instance. However, the only formal remedy is to apply to the courts:\nAn economic operator that suffers, or is at risk of suffering, loss, or damage attributable to a breach of duty under the Public Contracts (Scotland) Regulations 2015 or the Procurement Reform (Scotland) Act 2014, may bring proceedings in the Sheriff Court or the Court of Session.\nThe bringing of court proceedings against the Authority after the Framework Agreement has been entered into will not affect the Framework Agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the Framework Agreement has been entered into are limited to the award of damages.",
"classification": {
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
},
"mainProcurementCategory": "goods"
},
"parties": [
{
"id": "GB-FTS-322",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")",
"roles": [
"buyer"
],
"address": {
"region": "UKM",
"locality": "Edinburgh",
"postalCode": "EH12 9EB",
"countryName": "United Kingdom",
"streetAddress": "Gyle Square (NSS Head Office), 1 South Gyle Crescent"
},
"details": {
"url": "http://www.nss.nhs.scot/browse/procurement-and-logistics",
"buyerProfile": "https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883"
},
"identifier": {
"legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (\"NSS\")"
},
"contactPoint": {
"name": "Michelle Semple",
"email": "michelle.semple3@nhs.scot"
}
},
{
"id": "GB-FTS-11331",
"name": "Aventis Pharma Ltd Trading As Sanofi",
"roles": [
"supplier"
],
"address": {
"region": "UK",
"locality": "Reading",
"postalCode": "RG6 1PT",
"countryName": "United Kingdom",
"streetAddress": "410 Thames Valley Park Drive"
},
"details": {
"scale": "large"
},
"identifier": {
"legalName": "Aventis Pharma Ltd Trading As Sanofi"
},
"contactPoint": {
"telephone": "+44 1183543118"
}
},
{
"id": "GB-FTS-324",
"name": "Sheriff Court House",
"roles": [
"reviewBody"
],
"address": {
"locality": "Edinburgh",
"postalCode": "EH1 1LB",
"countryName": "United Kingdom",
"streetAddress": "27 Chambers Street"
},
"details": {
"url": "https://www.scotcourts.gov.uk/the-courts/court-locations/edinburgh-sheriff-court-and-justice-of-the-peace-court"
},
"identifier": {
"legalName": "Sheriff Court House"
},
"contactPoint": {
"email": "edinburgh@scotcourts.gov.uk"
}
}
],
"language": "en",
"contracts": [
{
"id": "020567-2023-NP92619(a-d)-1",
"items": [
{
"id": "1",
"relatedLot": "1",
"classification": {
"id": "33600000",
"scheme": "CPV",
"description": "Pharmaceutical products"
},
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014."
},
"deliveryAddresses": [
{
"region": "UKM"
}
]
}
],
"title": "NP92619 ERT Medicines",
"value": {
"amount": 20056400,
"currency": "GBP"
},
"period": {
"durationInDays": 360
},
"status": "active",
"awardID": "020567-2023-NP92619(a-d)-1",
"amendments": [
{
"id": "1",
"rationale": "Need for modification brought about by circumstances which a diligent contracting authority/entity could not foresee: This modification is necessary to meet the additional demands of the Scottish Health and Social Care sector during the Covid-19 pandemic and associated recovery, to maintain supply and remove unnecessary disruption from the Authority due to circumstances unforeseen by the Authority in line with Regulation 72(1)(c) of the Public Contracts (Scotland) Regulations 2015.",
"description": "This modification effects an extension of the Framework Agreement duration from 01 October 2023 until 30 September 2024. The modification notice covers the individual Framework Agreements. All Terms and Conditions of Contract remain in place."
}
],
"dateSigned": "2019-08-07T00:00:00+01:00"
}
],
"description": "The estimated values of the Framework Agreements referred to in Section V.2.4 covers the twenty one (21) month contract duration and the twenty seven (27) month extension period of the Framework Agreement.\nOJEU notice numbers for each of the individual Awards:\nNP92619(a)Aldurazyme®- 2019/S 170-415123\nNP92619(b)Cerezyme®- 2019/S 170-415129\nNP92619(c)Fabrazyme®- 2019/S 170-415117\nNP92619(d)Myozyme®- 2019/S 170-415133\n(SC Ref:730349)",
"initiationType": "tender"
}